Cannabielsoin, also known as CBE, is an analytical reference standard categorized as a phytocannabinoid metabolite. It serves as a metabolite of cannabidiol (CBD Cay-ISO60156 Cay-90080). Essentially, Cannabielsoin (Cay-21092) is utilized for research and forensic applications. This compound plays a significant role in the realm of phytocannabinoids and is crucial in various scientific investigations and analyses.

Cannabielsoin is a newly discovered metabolite of cannabidiol found in mammals. It is formed through the biotransformation of cannabidiol in plants like Cannabis sativa and Saccharum officinarum. Chemically, it is identified as (5aS,6S,9R,9aR)-6-methyl-3-pentyl-9-prop-1-en-2-yl-7,8,9,9a-tetrahydro-5aH-dibenzofuran-1,6-diol. Cannabielsoin, also known as CBE or Cannabielsoin I, has properties that make it potentially valuable in pharmacology and biochemistry. Further research may shed light on its therapeutic applications and potential benefits in various medical fields.